Your browser doesn't support javascript.
loading
Cryo-EM structure determination of small therapeutic protein targets at 3 Å-resolution using a rigid imaging scaffold.
Castells-Graells, Roger; Meador, Kyle; Arbing, Mark A; Sawaya, Michael R; Gee, Morgan; Cascio, Duilio; Gleave, Emma; Debreczeni, Judit É; Breed, Jason; Leopold, Karoline; Patel, Ankoor; Jahagirdar, Dushyant; Lyons, Bronwyn; Subramaniam, Sriram; Phillips, Chris; Yeates, Todd O.
Affiliation
  • Castells-Graells R; Department of Energy, Institute for Genomics and Proteomics, University of California, Los Angeles, CA 90095.
  • Meador K; Department of Chemistry and Biochemistry, University of California, Los Angeles, CA 90095.
  • Arbing MA; Department of Energy, Institute for Genomics and Proteomics, University of California, Los Angeles, CA 90095.
  • Sawaya MR; Department of Energy, Institute for Genomics and Proteomics, University of California, Los Angeles, CA 90095.
  • Gee M; Department of Chemistry and Biochemistry, University of California, Los Angeles, CA 90095.
  • Cascio D; Department of Energy, Institute for Genomics and Proteomics, University of California, Los Angeles, CA 90095.
  • Gleave E; Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom.
  • Debreczeni JÉ; Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom.
  • Breed J; Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom.
  • Leopold K; Gandeeva Therapeutics, Inc., Burnaby, British Columbia V5C 6N5, Canada.
  • Patel A; Gandeeva Therapeutics, Inc., Burnaby, British Columbia V5C 6N5, Canada.
  • Jahagirdar D; Gandeeva Therapeutics, Inc., Burnaby, British Columbia V5C 6N5, Canada.
  • Lyons B; Gandeeva Therapeutics, Inc., Burnaby, British Columbia V5C 6N5, Canada.
  • Subramaniam S; Gandeeva Therapeutics, Inc., Burnaby, British Columbia V5C 6N5, Canada.
  • Phillips C; Department of Biochemistry and Molecular Biology, The University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
  • Yeates TO; Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, United Kingdom.
Proc Natl Acad Sci U S A ; 120(37): e2305494120, 2023 09 12.
Article in En | MEDLINE | ID: mdl-37669364
Cryoelectron microscopy (Cryo-EM) has enabled structural determination of proteins larger than about 50 kDa, including many intractable by any other method, but it has largely failed for smaller proteins. Here, we obtain structures of small proteins by binding them to a rigid molecular scaffold based on a designed protein cage, revealing atomic details at resolutions reaching 2.9 Å. We apply this system to the key cancer signaling protein KRAS (19 kDa in size), obtaining four structures of oncogenic mutational variants by cryo-EM. Importantly, a structure for the key G12C mutant bound to an inhibitor drug (AMG510) reveals significant conformational differences compared to prior data in the crystalline state. The findings highlight the promise of cryo-EM scaffolds for advancing the design of drug molecules against small therapeutic protein targets in cancer and other human diseases.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Diagnostic Imaging Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Diagnostic Imaging Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2023 Type: Article